118 related articles for article (PubMed ID: 29724531)
1. Long non-coding RNA POLR2E rs3787016 is associated with the risk of papillary thyroid carcinoma in Chinese population.
Chen B; Li J; Yi C; Jiao Y; Gu X; Feng X
Pathol Res Pract; 2018 Jul; 214(7):1040-1044. PubMed ID: 29724531
[TBL] [Abstract][Full Text] [Related]
2. The POLR2E rs3787016 polymorphism is strongly associated with the risk of female breast and cervical cancer.
Chen B; Jiao Y; Yaolong F; Li T; Liu Y; Wang M; Xiuli G; Feng X
Pathol Res Pract; 2019 May; 215(5):1061-1065. PubMed ID: 30846411
[TBL] [Abstract][Full Text] [Related]
3. The association of
Chen B; Wang S; Ma G; Han J; Zhang J; Gu X; Feng X
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30291213
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNAs POLR2E rs3787016 C/T and HULC rs7763881 A/C polymorphisms are associated with decreased risk of esophageal cancer.
Kang M; Sang Y; Gu H; Zheng L; Wang L; Liu C; Shi Y; Shao A; Ding G; Chen S; Tang W; Yin J
Tumour Biol; 2015 Aug; 36(8):6401-8. PubMed ID: 25874495
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA POLR2E gene polymorphisms increased the risk of prostate cancer in a sample of the Iranian population.
Sattarifard H; Hashemi M; Hassanzarei S; Basiri A; Narouie B; Ghavami S
Nucleosides Nucleotides Nucleic Acids; 2019; 38(1):1-11. PubMed ID: 30587086
[TBL] [Abstract][Full Text] [Related]
6. The HOTAIR, PRNCR1 and POLR2E polymorphisms are associated with cancer risk: a meta-analysis.
Chu H; Chen Y; Yuan Q; Hua Q; Zhang X; Wang M; Tong N; Zhang W; Chen J; Zhang Z
Oncotarget; 2017 Jun; 8(26):43271-43283. PubMed ID: 28159929
[TBL] [Abstract][Full Text] [Related]
7. Associations of long non-coding RNAs HOTAIR, LINC00951, POLR2E and HULC polymorphisms with the risk of esophageal and esophagogastric junction cancer in a western population: a case-control study.
Baili E; Gazouli M; Lazaris AC; Kanavidis P; Boura M; Michalinos A; Charalabopoulos A; Liakakos T; Alexandrou A
Mol Biol Rep; 2024 Feb; 51(1):249. PubMed ID: 38300349
[TBL] [Abstract][Full Text] [Related]
8. The POLR2E rs3787016 polymorphism is associated with susceptibility to and prognosis of gastric cancer.
Zhang YK; Wu LL; Li TT; Cao DY; Zheng Q; Liu L
Neoplasma; 2021 May; 68(3):665-671. PubMed ID: 33847132
[TBL] [Abstract][Full Text] [Related]
9. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.
Dong G; Zhang R; Xu J; Guo Y
Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556
[TBL] [Abstract][Full Text] [Related]
10. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R
Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616
[TBL] [Abstract][Full Text] [Related]
11. Correlation between polymorphisms of BRAF gene and papillary thyroid carcinoma.
Jiang R; Zhao C; Xu H; Zhao M; Sun X; Wang X; Song W
Clin Endocrinol (Oxf); 2016 Mar; 84(3):431-7. PubMed ID: 25916409
[TBL] [Abstract][Full Text] [Related]
12. Are the SNPs of NKX2-1 associated with papillary thyroid carcinoma in the Han population of Northern China?
Ai L; Yu Y; Liu X; Wang C; Shi J; Sun H; Yu Q
Front Med; 2014 Mar; 8(1):113-7. PubMed ID: 24452548
[TBL] [Abstract][Full Text] [Related]
13. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.
Wang YL; Feng SH; Guo SC; Wei WJ; Li DS; Wang Y; Wang X; Wang ZY; Ma YY; Jin L; Ji QH; Wang JC
J Med Genet; 2013 Oct; 50(10):689-95. PubMed ID: 23847140
[TBL] [Abstract][Full Text] [Related]
14. The association between the Survivin A9194G exon polymorphisms and papillary thyroid carcinoma risk in the Han Chinese population.
Wang YX; Li ML; Yu SG; Liu CM; Han Y; Wang XY
Pathol Res Pract; 2013 Mar; 209(3):151-4. PubMed ID: 23414714
[TBL] [Abstract][Full Text] [Related]
15. Genetic predisposition to papillary thyroid carcinoma is mediated by a long non-coding RNA TINCR enhancer polymorphism.
Wang Q; Huang H; Chen P; Xiao X; Luo X; Wang Y; Long S; Gao L; Zhang L
Int Immunopharmacol; 2022 Aug; 109():108796. PubMed ID: 35489191
[TBL] [Abstract][Full Text] [Related]
16. Association of the miR-149 Rs2292832 polymorphism with papillary thyroid cancer risk and clinicopathologic characteristics in a Chinese population.
Wei WJ; Lu ZW; Li DS; Wang Y; Zhu YX; Wang ZY; Wu Y; Wang YL; Ji QH
Int J Mol Sci; 2014 Nov; 15(11):20968-81. PubMed ID: 25405731
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies.
Wei WJ; Lu ZW; Wang Y; Zhu YX; Wang YL; Ji QH
Cancer Genet; 2015 Mar; 208(3):68-75. PubMed ID: 25746573
[TBL] [Abstract][Full Text] [Related]
18. Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population.
Park SW; Kim MK; Kwon KH; Kim J
Int J Immunogenet; 2012 Dec; 39(6):501-7. PubMed ID: 22594576
[TBL] [Abstract][Full Text] [Related]
19. Role of Caspase 8, Caspase 9 and Bcl-2 polymorphisms in papillary thyroid carcinoma risk in Han Chinese population.
Wang YX; Zhao L; Wang XY; Liu CM; Yu SG
Med Oncol; 2012 Dec; 29(4):2445-51. PubMed ID: 22120515
[TBL] [Abstract][Full Text] [Related]
20. Onco-lncRNA HOTAIR and its functional genetic variants in papillary thyroid carcinoma.
Zhu H; Lv Z; An C; Shi M; Pan W; Zhou L; Yang W; Yang M
Sci Rep; 2016 Aug; 6():31969. PubMed ID: 27549736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
